Domo (DOMO) Competitors

Domo (NASDAQ:DOMO) and Enfusion (NYSE:ENFN) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, community ranking, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Does the MarketBeat Community believe in DOMO or ENFN?

Domo received 192 more outperform votes than Enfusion when rated by MarketBeat users. Likewise, 66.89% of users gave Domo an outperform vote while only 19.61% of users gave Enfusion an outperform vote.

Company	Underperform	Outperform
Domo	Outperform Votes 202 66.89%	Underperform Votes 100 33.11%
Enfusion	Outperform Votes 10 19.61%	Underperform Votes 41 80.39%

Do institutionals & insiders believe in DOMO or ENFN?

76.6% of Domo shares are held by institutional investors. Comparatively, 81.1% of Enfusion shares are held by institutional investors. 14.0% of Domo shares are held by company insiders. Comparatively, 36.4% of Enfusion shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Do analysts recommend DOMO or ENFN?

Domo presently has a consensus target price of $10.25, suggesting a potential upside of 25.61%. Enfusion has a consensus target price of $10.50, suggesting a potential downside of 8.66%. Given Domo's stronger consensus rating and higher probable upside, equities research analysts plainly believe Domo is more favorable than Enfusion.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Domo	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Enfusion	2 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has higher valuation and earnings, DOMO or ENFN?

Enfusion has lower revenue, but higher earnings than Domo. Domo is trading at a lower price-to-earnings ratio than Enfusion, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Domo	$318.99M	1.00	-$75.57M	-$2.19	-3.73
Enfusion	$174.54M	8.47	$6.03M	$0.04	287.45

Is DOMO or ENFN more profitable?

Enfusion has a net margin of 1.70% compared to Domo's net margin of -26.05%. Enfusion's return on equity of 6.67% beat Domo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Domo	-26.05%	N/A	-39.27%
Enfusion	1.70%	6.67%	4.86%

Which has more volatility and risk, DOMO or ENFN?

Domo has a beta of 2.49, indicating that its stock price is 149% more volatile than the S&P 500. Comparatively, Enfusion has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.

Does the media refer more to DOMO or ENFN?

In the previous week, Domo had 5 more articles in the media than Enfusion. MarketBeat recorded 8 mentions for Domo and 3 mentions for Enfusion. Domo's average media sentiment score of 0.67 beat Enfusion's score of 0.49 indicating that Domo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Domo	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Enfusion	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Domo and Enfusion tied by winning 8 of the 16 factors compared between the two stocks.